Por favor, espera, estamos cargando datos de gráficos
AstraZeneca PLC comunidad
About AstraZeneca PLC
What is AstraZeneca PLC?
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.
The current price of AstraZeneca PLC in the market is 190,99 $, with a 24-hour trading volume of 170,29M $. The asset's market cap is 591,95B $, after moving 105.87% in the last day.
Tokenized AstraZeneca PLC is trading at 99,42 $, with a tokenized market cap of 745,65K $ and a 24-hour trading volume of 675,32K $. The tokenized asset has moved 7.23% in the past 24 hours.